$BCRX Gali trial took 7 months to complete for phase 1/part1 for safety!!! No efficacy or immunogenicity data coming out...other companies did this kind of trials within 1-2 months...24 patients for 7 months to assess safety is borderline incompetence! Dr. Kalas who is responsible overseeing trial has a academic mindset with no inclination towards shareholder value creation!
  • 3
3 Likes